Alba Lecumberri, M.D., from the Hospital Universitario Ramón y Cajal in Madrid, and colleagues examined RI in patients with psoriasis undergoing biologic therapy in a prospective observational ...

Psoriasis, with its systemic inflammatory nature ... dysfunction to improve overall patient outcomes." Co-first author Alba Lecumberri, MD, Department of Dermatology, Hospital Universitario ...

ORLANDO, Fla. — Of the 12 biologics in four drug classes approved for treating psoriasis in the United States, interleukin 23 (IL-23) inhibitors might be exceptional, particularly if used early ...